Anticoagulant treatment in primary health care in Sweden - Prevalence, incidence and treatment diagnosis: A retrospective study on electronic patient records in a registered population

BMC Family Practice

Volumn 4, Issue , 2003, Pages 1-4

  Nilsson, Gunnar H ^a   Björholt, Ingela ^b   Johnsson, Hans ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG INDICATION; ELECTRONIC MEDICAL RECORD; EMBOLISM; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY HEALTH CARE; SEX DIFFERENCE; STROKE; SWEDEN;

EID: 3042626457     PISSN: 14712296     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2296-4-3     Document Type: Article

References (12)

1. Hart RG, Sherman DG, Easton JD and Cairns JA Prevention of stroke in patients with nonvalvular atrial fibrillation Neurology 1998, 51:674-681
2. Bick RL Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism Drugs 2000, 60:575-595
3. Verheugt FW Warfarin for ischemic heart disease Cardiol Rev 2001, 9:325-328
4. Jansson JH, Westman G, Boman K, Nilsson T and Norberg B Oral anticoagulant treatment in a medical care district - a descriptive study Scand J Prim Health Care 1995, 13:268-274
5. Wändell PE Anticoagulant treatment of patients in Swedish primary health care Eur J Clin Pharmacol 2001, 57:61-64
6. Lip GY, Golding DJ, Nazir M, Beevers DG, Child DL and Fletcher RI A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project Br J Gen Pract 1997, 7:285-289
7. Wändell PE Anticoagulant patients in Swedish primary health care. A comparison 5 years apart Scand J Prim Health Care 1998, 16:183-187
8. Eskola K, Aittoniemi P, Kurunmaki H, Latva-Nevala A, Paloneva M and Wallin AM Anticoagulant treatment in primary health care in Finland Scand J Prim Health Care 1996, 14:165-170
9. Taylor FC, Ramsay ME, Renton A and Cohen H Methods for managing the increased workload in anticoagulant clinics BMJ 1996, 312:286
10. Kalra L, Yu G, Perez I, Lakhani A and Donaldson N Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness BMJ 2000, 320:1236-1239
11. Azar AJ, Deckers JW, Rosendaal FR, van Bergen PF, van der Meer JF and Jonker JJ Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients Thromb Haemost 1994, 72:347-351
12. Mejhert M, Holmgren J, Wändell P, Persson H and Edner M Diagnostic tests, treatment and follow-up in heart failure patients - is there a gender bias in the coherence to guidelines? Eur J Heart Fail 1999, 1:407-10